Mitchell Glass

Dr. Mitchell Glass, MD, is a Director & Chief Medical Officer at Q/C Technologies, Inc., a Chairman at Accolade Pharma LLC and a Chief Executive Officer & Director at Chronic Airway Therapeutics Pty Ltd. He is on the Board of Directors at Q/C Technologies, Inc., Avatar Biotechnologies LLC, Orphagenix, Inc. and Chronic Airway Therapeutics Pty Ltd. Dr. Glass was previously employed as a Chief Medical Officer by Invion Ltd., a Chief Executive Officer by Aqumen Biopharmaceuticals NA, Inc., a Chief Scientific Officer by University City Science Center, a Chief Medical Officer & VP-Regulatory Affairs by AtheroGenics, Inc., a Director & Vice President by Smithkline Beecham Corp., a Principal by ICI Pharmaceuticals, a Chief Executive Officer by Aqumen Biopharmaceuticals KK, a Principal by Inverseon, Inc., a Chief Medical Officer & EVP-Research & Development by Invion Ltd., and a Principal by University of Pennsylvania.
He received his undergraduate degree from The University of Chicago and a doctorate degree from The University of Chicago.